Average Co-Inventor Count = 6.70
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (15 from 3,681 patents)
2. Other (1 from 832,680 patents)
16 patents:
1. 11713316 - Substituted naphthyridinone compounds useful as T cell activators
2. 11584747 - Substituted pyridopyrimidinonyl compounds useful as T cell activators
3. 11166959 - Isofuranone compounds useful as HPK1 inhibitors
4. 10954238 - Substituted naphthyridinone compounds useful as T cell activators
5. 10669272 - Substituted naphthyridinone compounds useful as T cell activators
6. 10035777 - Heterocyclic kinase inhibitors
7. 9932320 - Quinoline-based kinase inhibitors
8. 9737542 - Pyrrolotriazine kinase inhibitors
9. 9598423 - Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
10. 9273058 - Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
11. 7238699 - Imidazolyl derivatives as corticotropin releasing factor inhibitors
12. 7211669 - Imidazolyl derivatives as corticotropin releasing factor inhibitors
13. 6939968 - Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
14. 6888004 - Imidazolyl derivatives as corticotropin releasing factor inhibitors
15. 6239146 - Neurotrophic difluoroamide agents